Header Logo

Connection

DAVID ARCINIEGAS to Cognition Disorders

Back to Details
This is a "connection" page, showing publications DAVID ARCINIEGAS has written about Cognition Disorders.
DAVID ARCINIEGAS
Connection Strength
3.432
Cognition Disorders
  1. The DSM-5 approach to the evaluation of traumatic brain injury and its neuropsychiatric sequelae. NeuroRehabilitation. 2014; 34(4):613-23.
    View in: PubMed
    Score: 0.324
  2. Cholinergic dysfunction and cognitive impairment after traumatic brain injury. Part 2: evidence from basic and clinical investigations. J Head Trauma Rehabil. 2011 Jul-Aug; 26(4):319-23.
    View in: PubMed
    Score: 0.272
  3. Cholinergic dysfunction and cognitive impairment after traumatic brain injury. Part 1: the structure and function of cerebral cholinergic systems. J Head Trauma Rehabil. 2011 Jan-Feb; 26(1):98-101.
    View in: PubMed
    Score: 0.263
  4. Cognitive sequelae of hypoxic-ischemic brain injury: a review. NeuroRehabilitation. 2010; 26(1):47-63.
    View in: PubMed
    Score: 0.245
  5. Predictors of performance on the MMSE and the DRS-2 among American Indian elders. J Neuropsychiatry Clin Neurosci. 2010; 22(4):417-25.
    View in: PubMed
    Score: 0.245
  6. Depression and cognitive complaints following mild traumatic brain injury. Am J Psychiatry. 2009 Jun; 166(6):653-61.
    View in: PubMed
    Score: 0.236
  7. Long-term effects of rivastigmine capsules in patients with traumatic brain injury. Brain Inj. 2009 Feb; 23(2):123-32.
    View in: PubMed
    Score: 0.230
  8. Subtle neurological signs predict the severity of subacute cognitive and functional impairments after traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2009; 21(4):463-6.
    View in: PubMed
    Score: 0.229
  9. Pharmacotherapy of posttraumatic cognitive impairments. Behav Neurol. 2006; 17(1):25-42.
    View in: PubMed
    Score: 0.186
  10. Applications of the P50 evoked response to the evaluation of cognitive impairments after traumatic brain injury. Phys Med Rehabil Clin N Am. 2004 Feb; 15(1):177-203, viii.
    View in: PubMed
    Score: 0.163
  11. The cholinergic hypothesis of cognitive impairment caused by traumatic brain injury. Curr Psychiatry Rep. 2003 Oct; 5(5):391-9.
    View in: PubMed
    Score: 0.159
  12. Attention and memory dysfunction after traumatic brain injury: cholinergic mechanisms, sensory gating, and a hypothesis for further investigation. Brain Inj. 1999 Jan; 13(1):1-13.
    View in: PubMed
    Score: 0.114
  13. Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial. Neuropsychopharmacology. 2017 Aug; 42(9):1766-1775.
    View in: PubMed
    Score: 0.099
  14. Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations. Lupus. 2012 Apr; 21(4):402-11.
    View in: PubMed
    Score: 0.070
  15. Clinical electrophysiologic assessments and mild traumatic brain injury: state-of-the-science and implications for clinical practice. Int J Psychophysiol. 2011 Oct; 82(1):41-52.
    View in: PubMed
    Score: 0.067
  16. When cognitive evaluation does not disclose a neurologic disorder: experience of a university behavioral neurology clinic. Cogn Behav Neurol. 2010 Jun; 23(2):112-8.
    View in: PubMed
    Score: 0.063
  17. Using the Frontal Assessment Battery to identify executive function impairments in amyotrophic lateral sclerosis: A preliminary experience. Amyotroph Lateral Scler. 2010; 11(1-2):244-7.
    View in: PubMed
    Score: 0.061
  18. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. Arthritis Rheum. 2008 Nov 15; 59(11):1639-46.
    View in: PubMed
    Score: 0.057
  19. Neuropsychological patterns in systemic lupus erythematosus patients with depression. Arthritis Res Ther. 2007; 9(3):R48.
    View in: PubMed
    Score: 0.050
  20. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology. 2006 Sep 12; 67(5):748-55.
    View in: PubMed
    Score: 0.049
  21. Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data. Cogn Behav Neurol. 2005 Sep; 18(3):159-62.
    View in: PubMed
    Score: 0.045
  22. Amantadine for neurobehavioural deficits following delayed post-hypoxic encephalopathy. Brain Inj. 2004 Dec; 18(12):1309-18.
    View in: PubMed
    Score: 0.043
  23. Viral encephalitis: neuropsychiatric and neurobehavioral aspects. Curr Psychiatry Rep. 2004 Oct; 6(5):372-9.
    View in: PubMed
    Score: 0.043
  24. Predictors of cognitive decline following coronary artery bypass graft surgery. Ann Thorac Surg. 2004 Feb; 77(2):597-603; discussion 603.
    View in: PubMed
    Score: 0.041
  25. The thalamus and the schizophrenia phenotype: failure to replicate reduced volume. Biol Psychiatry. 1999 May 15; 45(10):1329-35.
    View in: PubMed
    Score: 0.029
  26. White matter abnormalities and working memory impairment in systemic lupus erythematosus. Cogn Behav Neurol. 2013 Jun; 26(2):63-72.
    View in: PubMed
    Score: 0.019
  27. Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. J Neurol Sci. 2010 Aug 15; 295(1-2):87-91.
    View in: PubMed
    Score: 0.016
  28. White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus. Cogn Behav Neurol. 2009 Mar; 22(1):38-44.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.